We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
10 Year Est. Return
AUM
$57.8M
AUM Growth
-$40.7M
Cap. Flow
-$18.9M
Cap. Flow %
-32.78%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ASTR
Astra Space, Inc. Class A Common Stock
ASTR
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 64.12%
2 Industrials 35.88%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDYA icon
1
IDEAYA Biosciences
IDYA
$3.54B
$36.7M 63.52%
2,660,713
BGRY
2
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$20.7M 35.88%
14,302,523
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
$346K 0.6%
115,545
ASTR
4
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
-464,911
Closed -$18.9M

Similar funds

Canaan Partners X's Q2 2022 Portfolio in Review

As of Q2 2022, Canaan Partners X held 4 positions worth $57.8M, down 41% from $98.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners X withdrew a net $18.9M in Q2 2022, closing 1 position. Its most notable exit was Astra Space, Inc. Class A Common Stock, an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Canaan Partners X fully exited Astra Space, Inc. Class A Common Stock in Q2 2022, selling an estimated $18.9M.
  • Canaan Partners X's ten largest holdings make up 100% of its $57.8M portfolio in Q2 2022.
  • Canaan Partners X opened 0 new positions and closed 1 in Q2 2022.
  • Canaan Partners X's portfolio value fell 41% quarter-over-quarter to $57.8M.

Based on Canaan Partners X's 13F filing for Q2 2022, filed 10 Aug 2022.